Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Other Working Capital Changes (2016 - 2026)

Lineage Cell Therapeutics has reported Other Working Capital Changes over the past 17 years, most recently at -$995000.0 for Q1 2026.

  • For Q1 2026, Other Working Capital Changes rose 22.2% year-over-year to -$995000.0; the TTM value through Mar 2026 reached $238000.0, up 102.72%, while the annual FY2025 figure was -$46000.0, 99.4% up from the prior year.
  • Other Working Capital Changes for Q1 2026 was -$995000.0 at Lineage Cell Therapeutics, down from $5.5 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $11.1 million in Q4 2022 and troughed at -$6.8 million in Q4 2024.
  • A 5-year average of -$514647.1 and a median of -$1.3 million in 2025 define the central range for Other Working Capital Changes.
  • On a YoY basis, Other Working Capital Changes climbed as much as 1665.31% in 2022 and fell as far as 5388.04% in 2022.
  • Year by year, Other Working Capital Changes stood at $11.1 million in 2022, then plummeted by 95.75% to $474000.0 in 2023, then crashed by 1532.28% to -$6.8 million in 2024, then skyrocketed by 181.71% to $5.5 million in 2025, then tumbled by 117.94% to -$995000.0 in 2026.
  • Business Quant data shows Other Working Capital Changes for LCTX at -$995000.0 in Q1 2026, $5.5 million in Q4 2025, and -$4.3 million in Q3 2025.